Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 5,313 ATRC shares, $288.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | AtriCure, Inc. (ATRC) | Sale | 5,313 | $288.1K |
| May 20, 2026 | AtriCure, Inc. (ATRC) | Grant/Award | 6,144 | n/a |
| May 18, 2026 | Fulgent Genetics, Inc. (FLGT) | Grant/Award | 11,117 | n/a |
| Aug 8, 2025 | AtriCure, Inc. (ATRC) | Sale | 2,452 | $90.3K |
| May 21, 2025 | AtriCure, Inc. (ATRC) | Grant/Award | 5,401 | n/a |
| May 19, 2025 | Fulgent Genetics, Inc. (FLGT) | Grant/Award | 8,982 | n/a |
| May 20, 2024 | Fulgent Genetics, Inc. (FLGT) | Grant/Award | 4,000 | n/a |
| May 14, 2024 | AtriCure, Inc. (ATRC) | Grant/Award | 7,788 | n/a |
| May 26, 2023 | AtriCure, Inc. (ATRC) | Grant/Award | 3,186 | n/a |
| May 22, 2023 | Fulgent Genetics, Inc. (FLGT) | Grant/Award | 6,759 | n/a |